secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES & COLVARD LTD (—)
CIK:        0001015155
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001104659-23-071201
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Charles & Colvard receives Nasdaq bid price deficiency notice; 180-day cure period
--------------------------------------------------------------------------------

- Nasdaq notified CTHR on June 12, 2023 that bid price closed below $1.00 for 30 consecutive business days.
- Company has until December 11, 2023 to regain compliance: bid price must close at $1.00+ for 10 consecutive days.
- If compliance not met, Nasdaq may grant an additional 180-day period if other listing standards are met.
- Failure to cure could lead to delisting; company may appeal any such determination.
- Management will monitor bid price and consider options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1015155/000110465923071201/0001104659-23-071201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1015155/000110465923071201/tm2318651d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-071201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer